Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phencyclidine increases vesicular dopamine uptake.

Michael J Crosby1, Jarom E Hanson, Annette E Fleckenstein

  • 1Department of Pharmacology and Toxicology, University of Utah, 30 South 2000 East, Salt Lake City, UT 84112, USA.

European Journal of Pharmacology
|March 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methcathinone self-administration decreases dopamine and serotonin transporter function in rats.

Drug and alcohol dependence·2026
Same author

Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotype.

Frontiers in psychiatry·2026
Same author

Differential Effects of Neurotensin NTS1 and NTS2 Receptors on Locomotion.

Brain and behavior·2025
Same author

Methcathinone decreases dopamine transporter function: Role of protein kinase C.

Journal of neurochemistry·2021
Same author

3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.

The Journal of pharmacology and experimental therapeutics·2020
Same author

Comprehensive oral care improves treatment outcomes in male and female patients with high-severity and chronic substance use disorders.

Journal of the American Dental Association (1939)·2019

Phencyclidine (PCP) enhances dopamine uptake by vesicles, a process blocked by dopamine D2 receptor antagonists. This reveals a new mechanism for how PCP affects dopamine neurons.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Phencyclidine (PCP) is a dissociative anesthetic known for its complex effects on the central nervous system.
  • Dopamine plays a crucial role in motor control, reward, and cognition, and its dysregulation is implicated in various neurological and psychiatric disorders.
  • Vesicular monoamine transporter-2 (VMAT-2) is essential for packaging monoamines, including dopamine, into synaptic vesicles.

Purpose of the Study:

  • To investigate the acute effects of phencyclidine (PCP) on vesicular dopamine uptake.
  • To explore the role of the N-methyl-D-aspartate (NMDA) receptor and dopamine D2 receptors in PCP's influence on dopamine transport.

Main Methods:

  • Administration of phencyclidine (PCP) and dizocilpine (MK-801) to rodents.

Related Experiment Videos

  • Measurement of vesicular dopamine uptake in striatal synaptosomes.
  • Assessment of VMAT-2 ligand binding.
  • Pharmacological blockade using the dopamine D2 receptor antagonist eticlopride.

    • Main Results:

    • PCP rapidly increased vesicular dopamine uptake and VMAT-2 ligand binding within 1 hour.
    • These effects returned to baseline levels 3 hours after high-dose PCP administration.
    • Dizocilpine (MK-801), another NMDA receptor antagonist, did not affect vesicular dopamine uptake.
    • Pretreatment with eticlopride blocked the PCP-induced increase in vesicular dopamine uptake.

    Conclusions:

    • PCP acutely enhances vesicular dopamine uptake via a mechanism involving dopamine D2 receptors.
    • This finding suggests a novel pathway through which PCP modulates dopamine neuronal function.
    • The results contribute to understanding the neurochemical basis of PCP's pharmacological actions.